Explore our new curriculum as steering committee experts discuss emerging insights into B-cell–targeted therapies in transforming IgAN care ... Show more
IgAN and the B Cell Pathway
Photo: medscape.org · view article
Medscape examines IgAN and the B-cell pathwayDated May 7, 2026, the page is an educational resource on immunoglobulin A nephropathy.
Key FactsMay 7, 2026 · Reading time: ~30 sec.
Summary created with AI assistance · Source: medscape.org
Summary created with AI assistance · Source: medscape.org
- The resource describes a rapidly expanding treatment landscape and agents that target the B-cell pathway.
- Under the heading “Steering Committee,” it lists Matthew R. Weir, Sharon Adler, Jonathan Barratt, Gaia Coppock, Richard Lafayette, Suneel Udani, and John Marsala.
- John Marsala is identified as a patient advocate and kidney transplant recipient in 2022.
- For the contributors, the page discloses financial relationships including consulting roles, speaking engagements, and research funding.
Story Details
| Last Updated | |
| Total Articles | 2 |
Main Topics
News on this topic
Explore our new curriculum as steering committee experts discuss emerging insights into B-cell–targeted therapies in transforming IgAN care ... Show more
Similar to This
Previous
Is a lifetime without kidney failure finally possible?
We are closer than ever. Experts discuss the shift from merely delaying progression to potentially ...
x.com/i/broadcasts/1OdJrOyVkOqxX
Next